On May 15, 2024, the members of the CTGCT hosted the review meeting for the Reporting Period 1of its EU-funded project at the Kemijski Inštitut in Ljubljana, in collaboration with representatives from its Advanced Partners ( Jane Kinghorn, Zsolt Sebestyen, Leila Amini and Anke Fuchs). The session aimed to provide EU officials and external independent reviewers with a comprehensive overview of the project’s progress, building on previously submitted deliverables and milestones.
The event welcomed Doru-Leonard Irimie, the EU project officer overseeing the initiative, alongside two distinguished independent external reviewers: Brandusa-Ioana Bitel, Deputy Director of the R&D Department at the University of Medicine and Pharmacy Carol Davila (Romania) and Harold Cremer, Group Leader at the Marseille Developmental Biology Institute (France).
Project Progress and Presentations
Led by Mojca Bencina, the CTGCT team and Advanced Partners delivered a series of presentations outlining the project’s advancements, challenges, and impact across key areas. Topics covered included:
-
Governance and Management
-
Research and Innovation Breakthroughs
-
Communication Strategies
-
Sustainability Plans
Each presentation focused on specific work packages, highlighting achievements, deviations from the proposal and future goals. The sessions proceeded smoothly, fostering constructive dialogue between the presenters and reviewers.
Next Steps
The CTGCT team now awaits detailed feedback from the EU and external reviewers, which will guide refinements to ensure the project remains aligned with its objectives and maximizes its societal and scientific impact.
Below are highlights from the meeting. Stay tuned for further updates as the CTGCT continues to drive transformative advancements in clinical trial governance and research.
